Iris Unimi Prodmetadata only
The CHK1 inhibitor Prexasertib is effective against in vitro models of aggressive thyroid carcinomas with defective p53 function
chk1, dna damage response, prexasertib, tp53, thyroid cancer, tyrosine kinase inhibitors, settore meds-08/a - endocrinologia
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 254362
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.